Clinical Trial Update: Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports termination of a Phase 1/2 study of SAR444881 administered alone and in combination with other therapeutics in participants w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SAR444881

Snippet

Sponsor: Sanofi | Conditions: Cancer, Neoplasm | Phase 1, Phase 2 | Status: TERMINATED